{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:37:44Z","timestamp":1790033864444,"version":"4.0.1"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Landes-Offensive zur Entwicklung Wissenschaftlich-\u00f6konomischer Exzellenz (LOEWE) of the State of Hessen Research Center for Translational Medicine and Pharmacology TMP"},{"name":"Else Kr\u00f6ner-Fresenius-Stiftung (DE) Research Training Group Translational Research Innovation-Pharma (TRIP)"},{"name":"Federal Ministry of Education and Research of Germany","award":["01 EC1401C"],"award-info":[{"award-number":["01 EC1401C"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Galderma F\u00f6rderkreis e.V."},{"name":"Fraunhofer Institute IME"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0182646","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T17:26:28Z","timestamp":1501867588000},"page":"e0182646","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["GM-CSF in murine psoriasiform dermatitis: Redundant and pathogenic roles uncovered by antibody-induced neutralization and genetic deficiency"],"prefix":"10.1371","volume":"12","author":[{"given":"Tatjana","family":"Scholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Weigert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Br\u00fcne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian D.","family":"Sadik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-3131","authenticated-orcid":true,"given":"Harald","family":"Burkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"WH Boehncke","year":"2015","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"MA Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"A Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13555-015-0092-3","article-title":"A review of biologic therapies targeting IL-23 and IL-17 for use in moderate-to-severe plaque psoriasis","volume":"6","author":"M Campa","year":"2016","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"SL Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Y Lee","year":"2012","journal-title":"Nat Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12036","article-title":"Th17 cell development: from the cradle to the grave","volume":"252","author":"LA Z\u00fa\u00f1iga","year":"2013","journal-title":"Immunol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ni.2044","article-title":"GM-CSF: the secret weapon in the T(H)17 arsenal","volume":"12","author":"MJ McGeachy","year":"2011","journal-title":"Nat Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.4049\/jimmunol.178.8.5245","article-title":"Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation","volume":"178","author":"AJ Fleetwood","year":"2007","journal-title":"J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/annrheumdis-2013-204816","article-title":"MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib\/IIa randomised, double-blind, placebo-controlled, dose-escalation trial","volume":"74","author":"F Behrens","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/annrheumdis-2012-202450","article-title":"Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis","volume":"72","author":"GR Burmester","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3346\/jkms.1998.13.6.685","article-title":"Psoriasiform eruption triggered by recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF) and exacerbated by granulocyte colony stimulating factor (rG-CSF) in a patient with breast cancer","volume":"13","author":"SG Cho","year":"1998","journal-title":"J Korean Med Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2133.1993.tb00218.x","article-title":"Exacerbation of psoriasis with GM-CSF therapy","volume":"128","author":"R Kelly","year":"1993","journal-title":"Br J Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"L van der Fits","year":"2009","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.8171324","article-title":"Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis","volume":"264","author":"G Dranoff","year":"1994","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.freeradbiomed.2015.02.004","article-title":"Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8(+) T cell function by limiting GSH and Cys availability","volume":"83","author":"LK Sha","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood-2009-02-206318","article-title":"The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis","volume":"114","author":"D Kingston","year":"2009","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/10799900260100132","article-title":"Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines","volume":"22","author":"H Gary-Gouy","year":"2004","journal-title":"J Interferon Cytokine Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.173.3.1535","article-title":"Regulation of IFN regulatory factor-7 and IFN-alpha production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells","volume":"173","author":"J Dai","year":"2004","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0008-8749(02)00517-8","article-title":"Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod","volume":"218","author":"SJ Gibson","year":"2002","journal-title":"Cell Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1767","article-title":"Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells","volume":"10","author":"T Duhen","year":"2009","journal-title":"Nat Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1212\/NXI.0000000000000117","article-title":"Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis","volume":"2","author":"CS Constantinescu","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"Suppl. 2","key":"ref23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1468-3083.2006.01769.x","article-title":"Animal models of psoriasis: a brief update","volume":"20","author":"FO Nestle","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.4049\/jimmunol.1500551","article-title":"Dynamics and transcriptomics of skin dendritic cells and macrophages in an imiquimod-induced, biphasic mouse model of psoriasis","volume":"195","author":"D Terhorst","year":"2015","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature13199","article-title":"Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation","volume":"510","author":"L Riol-Blanco","year":"2014","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1346-8138.12367","article-title":"Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod","volume":"41","author":"A Ueyama","year":"2014","journal-title":"J Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.1102224","article-title":"IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice","volume":"188","author":"AB Van Belle","year":"2012","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/jid.2013.404","article-title":"IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions","volume":"134","author":"AL Croxford","year":"2014","journal-title":"J Invest Dermatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/jid.2012.512","article-title":"IL-1R1 signaling facilitates Munro's microabscess formation in psoriasiform imiquimod-induced skin inflammation","volume":"133","author":"M Uribe-Herranz","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"GK Perera","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.4049\/jimmunol.1302959","article-title":"Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis","volume":"192","author":"H Sumida","year":"2014","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/bjd.12631","article-title":"Bimodal immune activation in psoriasis","volume":"170","author":"E Christophers","year":"2014","journal-title":"Br J Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2133.1980.tb08145.x","article-title":"Razoxane (ICRF 159) in the treatment of psoriasis","volume":"102","author":"DJ Atherton","year":"1980","journal-title":"Br J Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1067\/mjd.2000.103264","article-title":"Rapid improvement of psoriasis vulgaris during drug-induced agranulocytosis","volume":"43","author":"E Toichi","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2008.09.016","article-title":"Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development","volume":"135","author":"B Cisse","year":"2008","journal-title":"Cell"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.immuni.2010.11.023","article-title":"Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells","volume":"33","author":"HS Ghosh","year":"2010","journal-title":"Immunity"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1182\/blood-2012-07-441311","article-title":"The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development","volume":"120","author":"HS Li","year":"2012","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"K Boniface","year":"2005","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2249.2007.03511.x","article-title":"A role for T cell-derived interleukin 22 in psoriatic skin inflammation","volume":"150","author":"K Boniface","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"K Wolk","year":"2006","journal-title":"Eur J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri1153","article-title":"Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators","volume":"3","author":"JC Renauld","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissue","volume":"21","author":"K Wolk","year":"2004","journal-title":"Immunity"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1038\/jid.2015.278","article-title":"Interleukin-22 promotes wound repair in diabetes by improving keratinocyte pro-healing functions","volume":"135","author":"S Avitabile","year":"2015","journal-title":"J Invest Dermatol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20021258","article-title":"Deficiencies of GM-CSF and interferon gamma link inflammation and cancer","volume":"197","author":"T Enzler","year":"2003","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3389\/fimmu.2015.00526","article-title":"Predominant role of plasmacytoid dendritic cells in stimulating systemic autoimmunity","volume":"6","author":"X Huang","year":"2015","journal-title":"Front Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0182646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:30:53Z","timestamp":1589034653000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0182646"}},"subtitle":[],"editor":[{"given":"Xiaonan","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0182646","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]}}}